Radiation is an important component of therapy for patients with stage III breast cancer who achieve a pathological complete response after neoadjuvant chemotherapy

被引：1
|
作者：
McGuire, SE [1 ]
Gonzalez-Angulo, AM [1 ]
Tucker, SL [1 ]
Rouzier, R [1 ]
Strom, EA [1 ]
Perkins, GH [1 ]
Oh, JL [1 ]
Huang, EH [1 ]
Sahin, AA [1 ]
Hunt, KK [1 ]
Hortobagyi, GN [1 ]
Buchholz, TA [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2005年 / 63卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2005.07.091
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
085
引用
收藏
页码：S52 / S52
页数：1
相关论文
共 50 条
  • [1] Consolidative Radiation Therapy for Stage III Hodgkin Lymphoma in Patients Who Achieve Complete Response After ABVD Chemotherapy
    Phan, Jack
    Mazloom, Ali
    Abboud, Mirna
    Salehpour, Mohammad
    Reed, Valerie
    Zreik, Tony
    Shihadeh, Ferial
    Fisher, Christine
    Wogan, Christine
    Dabaja, Bouthaina
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (05): : 499 - 505
  • [2] Pathological Complete Response Patients after Neoadjuvant Chemotherapy in Breast Cancer
    Takaoka, Megumi
    Ohsumi, Shozo
    Ikejiri, Haruka
    Shidahara, Tomohiro
    Miyoshi, Yuichiro
    Takahashi, Mina
    Takashima, Seiki
    Aogi, Kenjiro
    [J]. ACTA MEDICA OKAYAMA, 2022, 76 (02) : 105 - 111
  • [3] Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients
    Goorts, Briete
    van Nijnatten, Thiemo J. A.
    de Munck, Linda
    Moossdorff, Martine
    Heuts, Esther M.
    de Boer, Maaike
    Lobbes, Marc B. I.
    Smidt, Marjolein L.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2017, 163 (01) : 83 - 91
  • [4] Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients
    Briete Goorts
    Thiemo J. A. van Nijnatten
    Linda de Munck
    Martine Moossdorff
    Esther M. Heuts
    Maaike de Boer
    Marc B. I. Lobbes
    Marjolein L. Smidt
    [J]. Breast Cancer Research and Treatment, 2017, 163 : 83 - 91
  • [5] Better overall survival in patients who achieve pathological complete response after neoadjuvant chemotherapy for breast cancer in a Chilean public hospital
    Acevedo, Francisco
    Petric, Militza
    Walbaum, Benjamin
    Robin, Julieta
    Legorburu, Luisa
    Murature, Geraldine
    Guerra, Constanza
    Navarro, Marisel
    Jose Canovas, Maria
    Sanchez, Cesar
    Vargas, Lorena
    Manzor, Manuel
    Pena, Jose
    Muniz, Sabrina
    Veglia, Paulina
    Cartes, Raul
    Martinez, Raul
    [J]. ECANCERMEDICALSCIENCE, 2021, 15
  • [6] Predictors of distant metastasis in patients with triple negative breast cancer who failed to achieve a pathological complete response after neoadjuvant chemotherapy
    Tricarico, C. J.
    Gabani, P.
    Weiner, A. A.
    Ochoa, L. L.
    Thomas, M. A.
    Zoberi, I.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [7] Characteristics of breast cancer patients with pathological complete response after neoadjuvant chemotherapy
    Kolacinska, Agnieszka
    Blasinska-Morawiec, Maria
    Dowgier-Witczak, Izabela
    Kordek, Radzislaw
    Morawiec, Zbigniew
    [J]. MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2010, 9 (05): : 300 - 304
  • [8] Conversion of immunohistochemical markers and breast density are associated with pathological response and prognosis in very young breast cancer patients who fail to achieve a pathological complete response after neoadjuvant chemotherapy
    Zhao, Yue
    Wang, Xiaolei
    Huang, Yuanxi
    Zhou, Xianli
    Zhang, Dongwei
    [J]. CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 5677 - 5690
  • [9] MRI in diagnosis of pathological complete response in breast cancer patients after neoadjuvant chemotherapy
    Li, Yan-Ling
    Zhang, Xiao-Peng
    Li, Jie
    Cao, Kun
    Cui, Yong
    Li, Xiao-Ting
    Sun, Ying-Shi
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2015, 84 (02) : 242 - 249
  • [10] The surgical management of patients who achieve a complete pathological response after primary chemotherapy for locally advanced breast cancer
    Clouth, B.
    Chandrasekharan, S.
    Inwang, R.
    Smith, S.
    Davidson, N.
    Sauven, P.
    [J]. EJSO, 2007, 33 (08): : 961 - 966
12345